This Biotech Stock Soared: Why One Fund Sold $3 Million
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Volatility of index funds for retirement can be managed through thoughtful allocation, rebalancing, and a long-term perspective.
23,009 articlesA biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
When a chief executive sells stock after exercising options, investors often wonder if confidence underpins the move....
AI hype promises a smarter tomorrow, but the costs show up in everyday life—higher bills, stressed sleep, and tougher...
eXp World Holdings posts strong first-quarter results as agent productivity rises and it taps NextHome to broaden its...
Investors react to a key vote in the semiconductor space as IonQ jumps on the SkyWater deal. Here’s what it means for...
As housing demand cools, Home Depot and Lowe’s diverge on dividend resilience. Home Depot shows stronger cash flow an...
Learn how to analyze Baer’s Q1 2026 earnings call. This guide breaks down the numbers, guidance, and what it means fo...
3D Systems' Q1 2026 update sheds light on demand, margins, and cash flow across its printing systems, materials, and ...
Pi Network pushes forward with key KYC milestones as the Core Team signals momentum in its comeback. Over 18 million ...
Fan tokens are shifting from novelty to data assets, with clubs using on chain activity to measure sentiment, reward ...
A hantavirus outbreak can spark biotech chatter, but three solid realities—limited demand, tough development paths, a...
Inflation cools unevenly as growth slows, and the fed’s worst-case scenario quietly unfolds. Investors reassess risk ...